Forecasting The Future: 18 Analyst Projections For Biogen
Forecasting The Future: 18 Analyst Projections For Biogen
预测未来：分析师对Biogen的18项预测
During the last three months, 18 analysts shared their evaluations of Biogen (NASDAQ:BIIB), revealing diverse outlooks from bullish to bearish.
在过去的三个月中，18位分析师分享了他们对Biogen（纳斯达克股票代码：BIIB）的评估，揭示了从看涨到看跌的不同前景。
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
下表简要介绍了他们最近的评级，展示了过去30天情绪的演变，并将其与前几个月进行了比较。
Insights from analysts' 12-month price targets are revealed, presenting an average target of $302.44, a high estimate of $364.00, and a low estimate of $240.00. Experiencing a 5.59% decline, the current average is now lower than the previous average price target of $320.36.
分析师12个月目标股价的见解得以公布，平均目标股价为302.44美元，最高估计为364.00美元，低估值为240.00美元。目前的平均价格下降了5.59％，现在低于之前的平均目标股价320.36美元。
Interpreting Analyst Ratings: A Closer Look
解读分析师评级：仔细观察
In examining recent analyst actions, we gain insights into how...
在研究分析师最近的行...
登录免费看全文
登录/注册